NDC codes

FDA NDC Directory
Product NDC (as listed)51407-866Labeler and product segments. Claims need a package NDC.
Product NDC at billing width51407-0866Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
51407-866-60514070866605140708666060 TABLET, FILM COATED in 1 BOTTLE (51407-866-60)Marketed from Jun 9, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Lamivudine
Generic name (nonproprietary)
lamivudine
Active ingredients
Lamivudine — 100 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Golden State Medical Supply, Inc.NDC labeler code 51407
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 202941
Marketing start
Listing expires
Other FDA classes
Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
Identifiers
Product ID 51407-866_3c301c61-8245-0ad5-e063-6294a90a7b71SPL ID 3c301c61-8245-0ad5-e063-6294a90a7b71SPL set ID 3c30216d-f9f5-104b-e063-6294a90af8fdRxCUI 205328UNII 2T8Q726O95
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407086660 followed by a unit qualifier and the quantity

Package 51407-0866-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Lamivudine tablets (HBV) are indicated for the treatment of chronic hepatitis B virus (HBV) infection associated with evidence of hepatitis B viral replication and active liver inflammation [ see Clinical Studies ( 14.1 , 14.2 ) ]. The following points should be considered when initiating therapy with lamivudine tablets (HBV): Due to high rates of resistance development in treated patients, initiation of treatment with lamivudine tablets (HBV) should only be considered when the use of an alternative antiviral agent with a higher genetic barrier to resistance is not available or appropriate. Lamivudine tablets (HBV) have not been evaluated in patients co-infected withhuman immunodeficiency vi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51407-866

What is NDC 51407-866?
51407-866 is the product NDC for Lamivudine, Lamivudine 100 mg/1 tablet, film coated, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Lamivudine.
What is the active ingredient?
Lamivudine.
Who is the labeler?
Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lamivudine?
23 other product NDCs are listed under this name. See all Lamivudine NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lamivudine NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
LamivudineLamivudine 150 mg/1Tablet, Film coatedOralCoupler LLC67046-145967046-1459-03
LamivudineLamivudine 150 mg/1Tablet, Film coatedOralAmerican Health Packaging60687-72060687-0720-21
LamivudineLamivudine 150 mg/1Tablet, Film coatedOralMacleods Pharmaceuticals Limited33342-00133342-0001-09
LamivudineLamivudine 300 mg/1Tablet, Film coatedOralMacleods Pharmaceuticals Limited33342-00233342-0002-07
lamivudineLamivudine 100 mg/1Tablet, Film coatedOralCamber Pharmaceuticals, Inc.31722-00131722-0001-0231722-0001-60
LamivudineLamivudine 150 mg/1Tablet, Film coatedOralStrides Pharma Science Limited64380-71064380-0710-03
LamivudineLamivudine 300 mg/1Tablet, Film coatedOralStrides Pharma Science Limited64380-71164380-0711-04
LamivudineLamivudine 150 mg/1TabletOralIngenus Pharmaceuticals, LLC50742-62350742-0623-60
LamivudineLamivudine 300 mg/1TabletOralIngenus Pharmaceuticals, LLC50742-62450742-0624-60
LamivudineLamivudine 10 mg/mLSolutionOralRising Pharma Holdings, Inc.57237-27457237-0274-24

All 24 Lamivudine NDCs

Other NDCs under ANDA 202941

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202941
ProductStrengthForm · routeLabelerProduct NDC
LamivudineLamivudine 100 mg/1Tablet, Film coatedOralApotex Corp.60505-3250

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in